Lito Sousa: Medicinal Product Arriving in Brazil - 13/09/2026 - Equilibrio E Saúde
11 Articles
11 Articles
Lito Sousa in video published on Friday (4) Reproduction A joint operation between the Federal Revenue and the National Agency for Health Surveillance (Anvisa) allowed the rapid release of the experimental drug intended for the treatment of the influencer Lito Sousa, diagnosed with Creutzfeldt-Jakob disease. Agility was necessary because the therapeutic potential of the substance decreases rapidly over the hours. On September 4, Anvisa authorize…
Federal Revenue and Anvisa anticipated procedures to release the medication a few minutes after their arrival in Brazil
The Federal Revenue released in a few minutes at São Paulo International Airport in Guarulhos, on September 11, 2026, an emergency medicine taken by helicopter to pilot Lito Sousa, 59, served at Einstein Israeli Hospital. The cargo arrived in the country at the end of the night of September 11, 2026 to [...]
Everything worked out. The experimental medicine of the Sousa Lito arrived this weekend, it is already at Albert Einstein Hospital in São Paulo, and the pilot should receive the dose of the medicine at any time. And everything happened after an urgent operation of the Federal Revenue and the Anvisa to develop the medicine as soon as [...]
Substance will be used experimentally in the treatment of Lito Sousa after exceptional authorisation of Anvisa
Joint operation of Anvisa and the Federal Revenue has accelerated the release of the drug for the treatment of the influencer
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
